40% of CVS Caremark’s PBM clients have a negative specialty drug trend

About 40 percent of CVS Caremark clients saw negative specialty drug trends during the first three quarters of 2021, according to a report the pharmacy giant released Feb. 24.

Advertisement

Three takeaways from the report:

  1. CVS Caremark maintained an overall drug trend for its clients at 2.4 percent during the first three quarters of 2021.
  2. CVS Caremark managed an industry-low specialty drug trend of 5.8 percent.
  3. About 85 percent of CVS Caremark clients saw a specialty drug trend lower than 10 percent.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.